Intelligent Bio Solutions Inc. · NASDAQ:INBS

Intelligent Bio Solutions — Investor Presentation (December 2022)

15 slides from Intelligent Bio Solutions's investor presentation, Dec 14, 2022

  1. Slide 1: Intelligent Bio Solutions: Pioneering Painfree Solutions

    i INTELLIGENT 46 BIO SOLUTIONS Pioneering Painfree Solutions (NASDAQ: INBS)

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain statements in this presentation may constitute “forward-looking” statements as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), the Private Securities L

  3. Slide 3: Investment Highlights

    Investment Highlights IBS Inc. develops non-invasive, real-time drug and point-of-care testing Pioneering biosensor testing platform adaptable to large markets with multiple applications and indications. ies INTELLIGENT BIO SOLUTIONS Commercially available and approved fingerprinting drug detection

  4. Slide 4: Product Portfolio

    Product Portfolio

  5. Slide 5: Product Portfolio

    Product Portfolio Simple, reliable fingerprint drug test Biosensor platform for diagnostic test Fingerprint based drug test R&D at Newcastle University Australia On site results in 10 minutes Printable Organic Thin Film Transistor Commercialized in the U.K. Saliva Glucose Biosensor undergoing clinal

  6. Slide 6: Intelligent Fingerprinting Platform

    Intelligent Fingerprinting Platform Providing a non-invasive, discreet, staff-friendly drug testing solution 3 Steps to —_ Portable Screeni ng Our system is compact and portable, for convenient drug screening whenever it's needed, in a variety of locations Simpler Drug Hygienic & Easy to use Thanks

  7. Slide 7: Biosensor Platform

    Biosensor Platform The Biosensor is a platform technology that can be adapted to 130 different analytes by modifying the top layer. Detection Element Biosensor Platform (OTFT) cox] [cox J Figure Above : BS INTELLIGE BIO SOLUTIO Biosensor design (a) cross-section through the sensor at the source-drai

  8. Slide 8: Intellectual Property

    Intellectual Property a © 12 worldwide patent family applications . . INTELLIGENT wBS Ny Sot LUTIONS 12 granted across 45 territories A further 1] territories pending Covering all aspects of fingerprint diagnostics Chemistry Screening cartridge technology Collection cartridge technology Fingerprint

  9. Slide 9: Market Opportunity

    Market Opportunity Leveraging Intelligent non-invasive diagnostic testing to address current global demands © INTELLIGENT 46S BIO SOLUTIONS

  10. Slide 10: Global Drug Screening Market

    Global Drug Screening Market Global Drug Screening Market to Reach $11.6B Billion by 2026": Amid the COVID-19 crisis, the global market for Drugs of Abuse Testing estimated at US$4.8 Billion in the year 2020 Projected to reach a revised size of US$11.6B by 2026. $3.3B in the US alone. Growing at a C

  11. Slide 11: Global Diabetes Market

    Global Diabetes Market Market Facts and Figures! VN INTELLIGENT BIO SOLUTIONS The total number of people with diabetes Is predicted to rise to 643 million (1 in 9 adults) by 2030 and 784 million (1 in 8 adults) by 2045. 4in 5 people with diabetes (81%) live in low income and middle-income countries.

  12. Slide 12: Achievements and Team

    Achievements and Team @ INTELLIGENT WBS sieccuusiene

  13. Slide 13: Completed & Anticipated Milestones

    Completed & Anticipated Milestones Corporate Clinical Manufacturing Government Kd INTELLIGENT 4B B10 SOLUTIO @ Surpassed @ UK Sales from 2021 IFP merges Anticipated () with GBS @ product launch in Inc. Australia DSR software upgrade to Anticipated completion of mile @ improve user experience @ stone

  14. Slide 14: Leadership Team Bios

    Leadership Team Bios © Dr. Steven Boyages @ Harry Simeonidis Spiro Sakiris Philip Hand M.D., MB, BS, Ph.D. Chairman of the Board Dr. Boyages is a practicing clinician in endocrinology with 30+ years’ experience in medicine, including multiple executive positions. WESTMEAD HOSPITAL LIGENT LUTIONS iB

  15. Slide 15: Thank You

    Thank You Leveraging the power of biotechnology to transform non-invasive diagnostic testing and improve lives. @ INTELLIGENT 48 BIO SOLUTIONS

Intelligent Bio Solutions — Investor Presentation (December 2022) on 6ix